Bismuth

05/01/2011 - "To evaluate the efficacy of bismuth-based quadruple therapy as the first-line treatment for H.pylori infection. "
05/01/2011 - "[Efficacy of bismuth-based quadruple therapy as first-line treatment for Helicobacter pylori infection]."
06/01/1996 - "pylori colonization, 200 mg/kg of bismuth, given as RBC, eradicated the organism from all mice while only 10% of infections were eradicated by equivalent levels of bismuth in admixture form. "
08/01/2013 - "The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study."
05/01/2010 - "A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial."

04/24/1971 - "The efficacy of a bismuth-protein-complex compound in the treatment of gastric and duodenal ulcers."
01/01/2008 - "[Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease]."
01/01/1995 - "[Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs]."
08/01/1994 - "The beneficial effect of bismuth on duodenal ulcer disease is thought to be due to an effect on Helicobacter pylori, although it has a rather weak bactericidal effect on H. "
08/01/1991 - "Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse."

01/01/1997 - "In a prospective study designed to assess the effect of duration of antibiotic therapy on the helicobactericidal and ulcer healing efficacy of bismuth therapy, groups of patients, 10 in each group, with H. "
02/01/1992 - "After bismuth treatment 86% (19/22) of ulcers had healed if H pylori had been cleared, whereas only 65% (11/17) had healed if H pylori persisted (NS). "
01/01/1988 - "A bismuth compound can perhaps prolong the period of clinical remission in a subgroup of patients in whom campylobacter pylori do not recur after finalized ulcer healing treatment. "
07/07/2010 - "Our results are in good agreement with earlier biological data and suggest that HspA can be a potential target of the bismuth anti-ulcer drug against H. "
05/01/2006 - "To determine the long-term outcomes in terms of Helicobacter pylori and ulcer recurrence after second-line eradication with bismuth-containing quadruple regimens in Korea. "

04/01/1986 - "When patients with symptoms caused by gastritis are identified dual antibacterial treatment, combining the action of bismuth in the stomach with a systemic antibiotic, can eradicate C pyloridis, with remission of symptoms and restoration of normal epithelial morphology. "
06/20/1989 - "Recent studies raise the prospect that treatment with bismuth improves gastritis and is successful in treating symptoms in the Campylobacter pylori positive and negative patients. "
01/01/2014 - "pylori infected gastritis patients were randomized to receive 7- or 14-day standard triple therapy plus bismuth with probiotic or placebo. "
05/01/2009 - "Thus, in order to achieve higher Hp eradication ratios in follicular gastritis, duration of the triple-drug treatment might be lengthened or bismuth salt preparations need to be added to triple combination therapies."
02/01/1991 - "Bismuth preparations are becoming popular in the treatment of gastritis; close attention to neurological and psychiatric symptoms seems mandatory."

12/01/1993 - "Bismuth compounds as used in the treatment of peptic ulcer were labeled with 205Bi for absorption studies in animals and subjects."
03/30/1968 - "Pilot trial of a colloidal bismuth preparation in the treatment of peptic ulcer."
10/01/2014 - "Effect of licorice versus bismuth on eradication of Helicobacter pylori in patients with peptic ulcer disease."
05/01/2002 - "Bismuth-containing drugs have several applications, one being their use against Helicobacter pylori-associated peptic ulcers, and bismuth has been discovered in macrophages at the base and margins of peptic ulcers. "
02/01/2001 - "Bismuth-containing drugs are widely used in the treatment of Helicobacter pylori associated peptic ulcer. "